RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+35.63%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$969M
AUM Growth
+$969M
Cap. Flow
+$44.9M
Cap. Flow %
4.63%
Top 10 Hldgs %
77.9%
Holding
37
New
5
Increased
8
Reduced
7
Closed
7

Top Buys

1
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$16.9M
2
AVXS
AveXis, Inc. Common Stock
AVXS
$16.2M
3
PTGX icon
Protagonist Therapeutics
PTGX
$15.9M
4
BOLD
Audentes Therapeutics, Inc
BOLD
$12.6M
5
ARDX icon
Ardelyx
ARDX
$12.3M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
$27.7M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$17M
3
NTRA icon
Natera
NTRA
$9.45M
4
AGRX
Agile Therapeutics, Inc
AGRX
$6.49M
5
CDTX icon
Cidara Therapeutics
CDTX
$4.24M

Sector Composition

1 Healthcare 96.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.53B
$230M 23.74% 7,088,651 – –
ACHN
2
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$97.5M 10.05% 12,033,220 – –
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$74M 7.63% 3,681,491 +268,634 +8% +$5.4M
AVXS
4
DELISTED
AveXis, Inc. Common Stock
AVXS
$71.4M 7.36% 1,732,274 +392,892 +29% +$16.2M
SIOX
5
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$70M 7.22% 5,000,000 – –
NKTR icon
6
Nektar Therapeutics
NKTR
$568M
$63M 6.49% 3,664,154 +439,300 +14% +$7.55M
ARDX icon
7
Ardelyx
ARDX
$1.53B
$42.3M 4.36% 3,266,045 +953,802 +41% +$12.3M
ACRS icon
8
Aclaris Therapeutics
ACRS
$209M
$39.6M 4.09% 1,547,152 -1,080,567 -41% -$27.7M
TGTX icon
9
TG Therapeutics
TGTX
$4.65B
$35.8M 3.7% 4,631,114 +99,400 +2% +$769K
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
$31.5M 3.24% 2,656,166 +204,929 +8% +$2.43M
NGNE icon
11
Neurogene
NGNE
$264M
$29.3M 3.02% 2,191,977 +500,000 +30% +$6.68M
AIMT
12
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$19.4M 2% 1,292,940 – –
FOMX
13
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$16.9M 1.74% +1,820,138 New +$16.9M
PTGX icon
14
Protagonist Therapeutics
PTGX
$3.67B
$15.9M 1.64% +754,411 New +$15.9M
TARA icon
15
Protara Therapeutics
TARA
$120M
$15.2M 1.57% 1,626,931 – –
DRNA
16
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14.3M 1.47% 2,428,571 – –
BCRX icon
17
BioCryst Pharmaceuticals
BCRX
$1.74B
$13.2M 1.36% 2,989,795 – –
SBBP
18
DELISTED
Strongbridge Biopharma plc.
SBBP
$13.1M 1.35% 2,501,667 -173,671 -6% -$907K
BOLD
19
DELISTED
Audentes Therapeutics, Inc
BOLD
$12.6M 1.3% +707,426 New +$12.6M
DMTX
20
DELISTED
Dimension Therapeutics, Inc
DMTX
$12.4M 1.28% 1,548,033 – –
XLRN
21
DELISTED
Acceleron Pharma Inc.
XLRN
$11.5M 1.19% +318,565 New +$11.5M
ARWR icon
22
Arrowhead Research
ARWR
$3.05B
$11.2M 1.16% +1,525,424 New +$11.2M
TENX icon
23
Tenax Therapeutics
TENX
$27.3M
$5.53M 0.57% 2,389,700 – –
ONC
24
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$5.24M 0.54% 170,000 – –
ARCT icon
25
Arcturus Therapeutics
ARCT
$462M
$5.05M 0.52% 2,044,756 -988,155 -33% -$2.44M
1
2